Parkinson's disease clinical trials
805 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all parkinson's disease studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting parkinson's disease studies. A study counts once in each state where it has a site.
- California58
- Florida54
- New York53
- Texas48
- Ohio43
- Pennsylvania41
- Massachusetts38
- Michigan31
- Maryland30
- Connecticut29
- Minnesota29
- Arizona28
Also in China (105), Italy (88), France (73), Germany (54), Turkey (Türkiye) (53), United Kingdom (52), Canada (46), Spain (38).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 114
- Phase 138
- Phase 1 / Phase 220
- Phase 249
- Phase 2 / Phase 38
- Phase 322
- Phase 414
- No phase (devices, programs)390
- Observational250
Recently updated studies
Recruiting parkinson's disease studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 3NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Ages 18 Years and over · Phoenix, Arizona · Burbank, California +188 more · Merck Sharp & Dohme LLC
- RecruitingObservationalNCT07886879
Parkinson's Disease in Type 1 Gaucher Disease
Ages 40 Years and over · New York, New York · Icahn School of Medicine at Mount Sinai
- RecruitingPhase 2NCT06780085
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Ages 18 Years and over · Lexington, Kentucky · Baltimore, Maryland +31 more · Merck Sharp & Dohme LLC
- RecruitingPhase 2NCT07804615
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Ages 18 Years – 65 Years · Scottsdale, Arizona · Murrieta, California +27 more · Vima Therapeutics
- RecruitingNo phase (devices, programs)NCT06442033
Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial
Ages 18 Years and over · Cleveland, Ohio · Jay Alberts
- RecruitingPhase 2NCT07442747
Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
Ages 18 Years and over · Cleveland, Ohio · The Cleveland Clinic
- RecruitingNo phase (devices, programs)NCT01581580
Deep Brain Stimulation Surgery for Movement Disorders
Ages 18 Years – 99 Years · Bethesda, Maryland · National Institute of Neurological Disorders and Stroke (NINDS)
- RecruitingPhase 3NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Ages 18 Years and over · Bakersfield, California · Beverly Hills, California +197 more · Merck Sharp & Dohme LLC
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.